Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
公司代码GELS
公司名称Gelteq Ltd
上市日期Oct 29, 2024
CEOGivoni (Nathan Jacob)
员工数量7
证券类型Ordinary Share
年结日Oct 29
公司地址Level 4
城市MELBOURNE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Australia
邮编3205
电话61390873990
网址https://www.gelteq.com
公司代码GELS
上市日期Oct 29, 2024
CEOGivoni (Nathan Jacob)